DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study.

DEVELOPMENT and VALIDATION of a SCORE to IDENTIFY OLDER ADULTS at RISK of ADVERSE DRUG REACTIONS: An international multicenter study. - ADR risk score

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32352

Enrollment

150

Registered

2008-11-11

Start date

2008-11-12

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

risico-inschatting van risico op geneesmiddelbijwerkingen bij ouderen adverse drug reactions side effects of drugs

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All patients aged 65 and over, admitted to the participating Departments during the study period will be enrolled and followed until discharge or death.

Exclusion criteria

Exclusion criteria: 1.Age

Design outcomes

Primary

Measure	Time frame
The outcome of this study is the validation of the ADR-risk score. The score*s relationship with ADR will be assessed and Receiver Operating Characteristics (ROC) analyses will be performed to assess the ability of the score to predict ADR (sensitivity and specificity).	—

Countries

Netherlands

Outcome results